Healthcare News
Updated 3 times daily.  Select a news topic: Abortion ADHD Aid/Disasters Alcohol/Addiction/Illegal Drugs Allergy Alzheimer's Anxiety Arthritis Asthma/Respiratory Autism Bio-terrorism/Terrorism Biology/Biochemistry Bipolar Body Aches Bones/Orthopaedics Breast Cancer Cancer/Oncology Cardiovascular/Cardiology Caregivers/Homecare Cholesterol CJD/vCJD/Mad Cow Disease Cleft Palate Complementary Medicine Cosmetic Medicine/Plastic Surgery Crohn's Cystic Fibrosis Dentistry Depression Dermatology Diabetes Dyslexia Ear, Nose and Throat Endocrinology Epilepsy Erectile Dysfunction/Premature Ejaculation Eye Health/Optometry Fertility Flu/Bird Flu/SARS GastroIntestinal Genetics Gout Headache/Migraine Health Insurance/Medical Insurance Hearing/Deafness HIV/AIDS Huntingtons Disease Hypertension Immune System/Vaccines Infectious Diseases/Bacteria/Viruses Irritable-Bowel Syndrome IT/Internet/E-mail Liver Disease/Hepatitis Lung Cancer Lupus Lymphoma/Leukemia Medical Devices Medical Malpractice Medical Students Medicare/Medicaid Men's health Mental Health MRI/PET/Ultrasound MRSA/Drug Resistance Multiple Sclerosis Muscular Dystrophy Neurology/Neuroscience Nursing Nutrition/Agriculture Obesity/Overweight/Fitness Pain/Anesthetics Parkinson's Disease Pediatrics Pharma Industry Pregnancy Prostate Psychology/Psychiatry Public Health Radiology/Nuclear Medicine Rehabilitation Seniors/Aging Sexual Health/STDs Sleep/Sleep Disorders Smoking/Quit Smoking Sports Medicine/Fitness Statins Stem Cell Research Stroke Transplants/Organ Donations Tropical Diseases Urology/Nephrology Veterinary Water Quality Women's Health/OBGYN  Topic: Statins Netherlands Study Shows Need For Dose Management Care When Switching To Generic Statins Wed, 01 Sep 2010 Research conducted in the Netherlands has highlighted the need for care when switching patients under treatment for high cholesterol from branded to generic drug families. The study shows that much of the switching can result in patients inadvertently receiving non-equivalent doses, potentially leading to an increased risk of downstream heart disease and stroke... People At "Intermediate Risk" Of Heart Disease With Elevated HsCRP Benefit From Statin Therapy Even If Cholesterol Levels Are Normal Thu, 26 Aug 2010 Women and men with a 10-year cardiovascular disease risk of 5 percent or more and normal cholesterol levels but high levels of hsCRP, a protein associated with inflammation, could reduce their risk substantially with statin therapy, according to new research... People At 'Intermediate Risk' Of Heart Disease With Elevated HsCRP Benefit From Statin Therapy Even If Cholesterol Levels Are Normal Wed, 25 Aug 2010 Women and men with a 10-year cardiovascular disease risk of 5 percent or more and normal cholesterol levels but high levels of hsCRP, a protein associated with inflammation, could reduce their risk substantially with statin therapy, according to new research... Celera Publishes Review Article On The KIF6 Gene Variant As A Predictor Of Risk Of CHD And Reduction In Coronary Events From Statin Therapy Thu, 19 Aug 2010 Celera Corporation (NASDAQ:CRA) announced the publication of a review article on the KIF6 gene variant as a predictor of risk of coronary heart disease (CHD) and reduction of CHD events from statin therapy... Giving Out Statins With Junk Food Could Increase The Risk Of Diabetes Wed, 18 Aug 2010 New research claiming that fast food restaurants should give out statins to combat the effects of fatty food could encourage people to lead unhealthier lives and increase the risk of people developing Type 2 diabetes... Outlets Should Offer Free Statins With Junk Food Say UK Researchers Fri, 13 Aug 2010 Imagine this: order a cheeseburger and fries, and pick up a free cholesterol-busting statin tablet along with the other free condiments, that's what a group of UK researchers suggests you should be able to do at fast food outlets as a way to offset the increase in heart attack risk from eating junk food... Abbott's SIMCOR® (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths Fri, 06 Aug 2010 Abbott has received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR®, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin - the most commonly prescribed dose of simvastatin - with either 500 mg or 1,000 mg of niacin extended-release... Abbott's SIMCOR ® ( Niacin Extended-release / Simvastatin ) Receives FDA Approval For New Dosage Strengths Thu, 29 Jul 2010 Abbott (NYSE: ABT) received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR®, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin the most commonly prescribed dose of simvastatin with either 500 mg or 1,000 mg of niacin extended-release... Good Cholesterol Seems Less Important Once Statins Have Lowered Bad Cholesterol Fri, 23 Jul 2010 Results of an international trial suggest that once statins have lowered LDL or "bad" cholesterol, the level of HDL or "good" cholesterol is less important in terms of predicting cardiovascular risk than it is during pre-treatment assessment... Boca Raton Community Hospital Doctor Lead Author On Important New Statin Study Tue, 13 Jul 2010 Alexander Kulik, MD, MPH, a cardiovascular surgeon and endovascular specialist at Boca Raton Community Hospital, was the lead author in a peer-reviewed paper detailing the first large-scale study of statins and their impact on atrial fibrillation. Dr... New Study Reveals More Than Half Of Statin-Treated CVD Patients Are Not Reaching Optimal LDL-C Targets Tue, 13 Jul 2010 The analysis of the UK patient population from the DYSlipidaemia International Study (DYSIS UK), sponsored by MSD, found that 77.0% of the 383 statin-treated patients at high-risk from cardiovascular disease (CVD) who were studied achieved the JBS 2 guidelines' minimum standard of care*.(1) However, the study also found that 54... Insights Into Link Between Anti-Cholesterol Drugs And Depression Fri, 02 Jul 2010 Scientists are reporting a possible explanation for the symptoms of anxiety and depression that occur in some patients taking the popular statin family of anti-cholesterol drugs, and reported by some individuals on low-cholesterol diets. These symptoms could result from long-term, low levels of cholesterol in the brain, the report suggests. It appears in ACS' weekly journal Biochemistry... Statins Associated With Lower Cancer Recurrence Following Prostatectomy Tue, 29 Jun 2010 Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, according to researchers at Duke University Medical Center. Researchers also found that higher doses of the drugs were associated with lower risk of recurrence. The findings are published in the journal CANCER... Monitoring Cholesterol Increases Life Expectancy Tue, 08 Jun 2010 A University of Minnesota study definitively shows that those with decreased LDL cholesterol levels can count on an increased life expectancy. The research is published in the May 24 edition of the Annals of Surgery. The findings stem from the Program on Surgical Control of the Hyperlipidemias (POSCH) randomized controlled trial which kicked off at the University of Minnesota in 1975... Is There A Connection Between Statins And Tendon Ruptures? Mon, 31 May 2010 Michigan State University researchers are studying the role that statins - lifesavers for tens of millions of Americans trying to lower their cholesterol - play in causing disabling tendon ruptures. Francesca Dwamena, an associate professor in the College of Human Medicine's Department of Medicine, is leading the study, which will analyze more than 100,000 Blue Care Network enrollees... Statins And The Risk Of Liver Dysfunction, Acute Renal Failure, Cataracts And Myopathy Fri, 21 May 2010 Patients who are prescribed statins for heart disease should be closely monitored, because of the risk of unintended adverse effects (side effects), say researchers in a study published in the British Medical Journal (BMJ) today. A number of statins may raise the risk of liver dysfunction, acute renal failure, myopathy (diseases of muscle), and cataracts... Preoperative Statin Therapy Protects Elective Aneurysm Patients Fri, 21 May 2010 Preoperative statin therapy has a protective effect on patients undergoing elective abdominal aortic aneurysm (AAA) repair that reduces risk and subsequent total hospital costs according to a new study from researchers at the East Carolina Heart Institute in Greenville, North Carolina... Risk Of Clot-Related Diseases Decreased By Statins Mon, 17 May 2010 Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut. The results of the study were presented at the ATS 2010 International Conference in New Orleans... New Study Finds Post-Operative Statin Use May Help Improve Hip Replacement Outcomes Wed, 05 May 2010 The use of statins - drugs commonly prescribed to help lower cholesterol levels - may play an important role in decreasing complications among patients undergoing total hip replacement (THR), according to a study published in the May 2010 issue of The Journal of Bone and Joint Surgery (JBJS)... News From The Journal Of Clinical Investigation, May 3, 2010 Tue, 04 May 2010 IMMUNOLOGY: How statins modulate immune function Statins are a class of drug used to lower cholesterol levels in the blood. However, they also have many effects on the immune system, and it has been suggested that they might be useful for the treatment of inflammatory diseases mediated by immune cells known as T cells... Cholesterol Drugs May Help Improve Hip Replacement Outcomes Tue, 04 May 2010 The use of statins - drugs commonly prescribed to help lower cholesterol levels - may play an important role in decreasing complications among patients undergoing total hip replacement (THR), according to a study published in the May 2010 issue of The Journal of Bone and Joint Surgery (JBJS)... Association Of Statin And Nonsteroidal Anti-inflammatory Drug Use With Prostate Cancer Outcomes: Results From CaPSURE Tue, 04 May 2010 UroToday.com - Our study demonstrates an association of statin and NSAID use with lower all-cause mortality. While these findings may not represent a true causal relationship, they suggest that non-cancer mortality may be lessened in a cohort of prostate cancer patients. If all-cause mortality can be reduced, then the competing risk of prostate cancer-specific mortality (PCSM) may increase... Discovery Of Genetic Variance In Cancer Protection From Statin Drugs Thu, 22 Apr 2010 Researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have discovered why statins - popular drugs that lower cholesterol and appear to protect against colorectal cancer development - work for some people, but not for all... Study Finds Gene Test Reveals Who Could Benefit From Statins To Reduce Colon Cancer Risk Tue, 20 Apr 2010 A genetic test can help determine in which patients cholesterol-lowering statin drugs might have the most benefit in also reducing the risk of colorectal cancer, a new study from researchers at the University of Michigan Comprehensive Cancer Center finds... News From The Annals Of Internal Medicine, April 20, 2010 Tue, 20 Apr 2010 1. Rosuvastatin Reduces Risk of Major Cardiovascular Events in Healthy Older Adults Statins lower LDL cholesterol and C-reactive protein levels, both markers for cardiovascular disease risk...  Job Opportunities  Nursing Jobs  Nurse Practitioner Jobs  Candidate Registration  Nursing  Nurse Practitioner  Candidate Assistance  Making a Change  Resume Preparation  Interviewing Success  Questions to Ask  Questions to Anticipate  Counteroffers  Recruiting Solutions  Key Success Factors  Successful Hiring  Recruiting Process  Testimonials  Professional Information  CNS Scholarships  Leadership Resources  State Nursing License  State Nursing Associations  National Nursing Associations  Healthcare News  Information Search
Home Site Map Contact Us Feedback Privacy Disclaimer Refer To Friend Links Copyright © 1998-2006 Silver Oak Search Consultants, Inc. All Rights Reserved.